Gert Baas

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Older people’s attitudes towards deprescribing cardiometabolic medication

Stijn Crutzen, Jamila Abou, Sanne Smits et al. · BMC Geriatrics · 2021 · 60 citations · Full text

Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study

Stijn Crutzen, Gert Baas, Jamila Abou et al. · Frontiers in Pharmacology · 2020 · 56 citations · Full text

Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes

Stijn Crutzen, Gert Baas, Petra Denig et al. · Research in Social and Administrative Pharmacy · 2022 · 19 citations · Full text

Process evaluation of a pharmacist‐led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among adult people with type 2 diabetes

Gert Baas, Stijn Crutzen, Sanne Smits et al. · Basic & Clinical Pharmacology & Toxicology · 2023 · 18 citations · Full text